comparemela.com

Latest Breaking News On - Marie thibault - Page 11 : comparemela.com

Accuray (ARAY) Positioned for Growth: Buy Rating Supported by Chinese Market Expansion, New Product Launches, and Strong Financial Projections

Analyst Marie Thibault of BTIG reiterated a Buy rating on Accuray (ARAY – Research Report), with a price target of $7.00. Marie Thibault&#.

Boston Scientific to acquire Relievant Medsystems for $850M

Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Relievant Medsystems.

Insulin pump-makers grapple with questions about GLP-1s

These 2 Strong Buy Penny Stocks Could Soar to $17 (Or Higher), Say Analysts

Let’s take a moment to talk about opportunity, share price, and risk/reward considerations. These are some of the factors investors must consider when moving into penny stocks – and we haven’t even touched on the fundamental soundness of the company or its business model. Penny stocks – as their name suggests, they once traded for just a pennies per share, but these days are considered those equities trading at less than $5 – are a challenging market niche. The penny stock critics make valid poi

Abbott-Bigfoot Deal Proves That Diabetes Is a Hot Area for Digital Health Investment

This week, Abbott announced its plans to acquire Bigfoot Biomedical a startup selling a “smart” insulin pen cap, which collects data from a user’s CGM to help them calculate the right dose. Most analysts were unsurprised to hear of the acquisition given that the two companies have been collaborating for more than six years, but they said the deal reinforces the steady pace of digital innovation in the diabetes care space.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.